Cargando…
Therapeutic inhibition of SGK1 suppresses colorectal cancer
Colorectal cancer (CRC) is one of the leading causes of death worldwide. Thus, the development of new therapeutic targets for CRC treatment is urgently needed. SGK1 is involved in various cellular activities, and its dysregulation can result in multiple cancers. However, little is known about its ro...
Autores principales: | Liang, Xuchun, Lan, Chunling, Jiao, Guanming, Fu, Wencheng, Long, Xuesha, An, Yu, Wang, Kejin, Zhou, Jinzhe, Chen, Ting, Li, Yongqin, Xu, Jiahong, Huang, Qi, Xu, Bin, Xiao, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704191/ https://www.ncbi.nlm.nih.gov/pubmed/29170478 http://dx.doi.org/10.1038/emm.2017.184 |
Ejemplares similares
-
Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer
por: Liang, Xuchun, et al.
Publicado: (2017) -
Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC
por: Jiao, Guanming, et al.
Publicado: (2017) -
Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4
por: Xiao, Junjie, et al.
Publicado: (2017) -
N-glycosylated SGK196 suppresses the metastasis of basal-like breast cancer cells
por: Xu, Ci, et al.
Publicado: (2020) -
The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel
Therapeutic Target in Mantle Cell Lymphoma
por: Li, Jiao, et al.
Publicado: (2022)